OLMESARTAN/ AMLODIPINE Australia - englanti - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olmesartan/ amlodipine-myl is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 20 mg/5 mg/12.5 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide accord 20 mg/5 mg/12.5 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 20 mg/5 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 40 mg/10 mg/12.5 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide accord 40 mg/10 mg/12.5 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/10 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 40 mg/10 mg/25 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide accord 40 mg/10 mg/25 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/10 mg/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 40 mg/5 mg/12.5 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide accord 40 mg/5 mg/12.5 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/5 mg/12.5 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 40 mg/5 mg/25 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine/hydrochlorothiazide accord 40 mg/5 mg/25 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine; hydrochlorothiazide - film-coated tablet - 40 mg/5 mg/25 milligram(s) - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Olmesartan medoxomil/Amlodipine 20 mg/5 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine 20 mg/5 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine - film-coated tablet - 20/5 mg/mg - angiotensin ii antagonists and calcium channel blockers; olmesartan medoxomil and amlodipine

Olmesartan medoxomil/Amlodipine 40 mg/10 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine 40 mg/10 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine - film-coated tablet - 40/10 mg/mg - angiotensin ii antagonists and calcium channel blockers; olmesartan medoxomil and amlodipine

Olmesartan medoxomil/Amlodipine 40 mg/5 mg film-coated tablets Irlanti - englanti - HPRA (Health Products Regulatory Authority)

olmesartan medoxomil/amlodipine 40 mg/5 mg film-coated tablets

accord healthcare ireland ltd. - olmesartan medoxomil; amlodipine - film-coated tablet - 40/5 mg/mg - angiotensin ii antagonists and calcium channel blockers; olmesartan medoxomil and amlodipine

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE tablet, film coated Yhdysvallat - englanti - NLM (National Library of Medicine)

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet, film coated

teva pharmaceuticals usa, inc. - olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10), amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - olmesartan medoxomil 20 mg - olmesartan medoxomil, amlodipine, hydrochlorothiazide tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such